Physician

Federico Cerrone, M.D.

According to 2025 Medicare claims, Federico Cerrone, M.D. (NPI: 1184625220) practices sleep medicine in the Newark, NJ market, with the plurality of this provider's patient population coming from Union, NJ. This provider's primary affiliated billing organization is PRACTICE ASSOCIATES MEDICAL GROUP (NPI: 1427016385; TIN: 202088165) and primary practice location at 07901-4055. Cerrone is affiliated with the Atlantic ACO (ACO ID: A1026), participating under the MSSP model.

Cerrone's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,082 traditional Medicare patients, billed 1,650 HCPCS/CPT codes, and received $112,835 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 518 prescription claims across 128 beneficiaries totaling $283,675 in drug costs, led by Xywav (Sodium,calcium,mag,pot Oxybate). DME data shows 7,461 claims. Open Payments data shows 74 records totaling $6,386. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $150,980 to $112,835. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $200,438 and ending at $283,675. For DME billing, reported payments changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	804	2,021	$150,980
2016	946	3,404	$185,168
2017	910	1,840	$125,985
2018	1,021	1,994	$136,977
2019	1,076	1,935	$128,021
2020	881	1,396	$90,896
2021	938	1,587	$119,458
2022	1,091	1,548	$113,757
2023	1,044	1,512	$106,546
2024	1,082	1,650	$112,835

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	151	731	$200,438
2016	167	775	$199,037
2017	122	712	$182,067
2018	132	639	$191,546
2019	151	684	$236,196
2020	137	706	$247,387
2021	152	685	$208,439
2022	172	701	$231,984
2023	132	546	$162,150
2024	128	518	$283,675

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	2,663	4,882	$174,806
2016	3,621	7,411	$237,627
2017	3,949	8,363	$241,890
2018	4,819	10,221	$315,588
2019	4,186	8,723	$259,198
2020	3,924	8,659	$262,433
2021	3,799	7,924	$244,625
2022	3,862	8,761	$268,336
2023	3,597	7,679	$254,868
2024	3,586	7,461	$267,116

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	144	144	$129
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	155	226	$104
95810	Sleep study in sleep lab (6 years or older)	63	63	$97
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	382	467	$73
95800	Sleep study including heart rate, breathing, and sleep time	598	624	$30

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xywav	Sodium,calcium,mag,pot Oxybate	11	330	$211,382
Breo Ellipta	Fluticasone/Vilanterol	33	1,770	$23,387
Dulera	Mometasone/Formoterol	17	510	$6,061
Quviviq	Daridorexant Hcl	11	330	$5,675
Eszopiclone	Eszopiclone	125	4,755	$3,384

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A7030	Full face mask used with positive airway pressure device, each	N	271	565	$42,795
A7031	Face mask interface, replacement for full face mask, each	N	201	449	$34,839
E0601	Continuous positive airway pressure (cpap) device	Y	202	1,107	$31,705
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	330	683	$31,652
A7032	Cushion for use on nasal mask interface, replacement only, each	N	152	338	$28,226

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	74	$6,386	Inspire Medical Systems, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Federico Cerrone, M.D.?

Tedicare shows public-source Medicare data for Federico Cerrone, M.D. (NPI 1184625220), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Federico Cerrone, M.D. have ACO affiliation data?

Federico Cerrone, M.D. is shown with ACO affiliation data for Atlantic ACO (MSSP, ACO ID A1026).

What billing organization is linked to Federico Cerrone, M.D.?

Federico Cerrone, M.D. is linked to PRACTICE ASSOCIATES MEDICAL GROUP (billing NPI 1427016385) in the available physician profile data.

Does Federico Cerrone, M.D. have Open Payments data?

Federico Cerrone, M.D. has 74 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.